Aaron Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Aaron Wealth Advisors's REGN Position: Q2 2026 in Review
Aaron Wealth Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, selling an estimated $108K and leaving 944 shares worth $589K. The position accounts for 0.03% of the portfolio, ranked #375.
Aaron Wealth Advisors first reported a position in REGN in Q1 2022 and has held it in 10 quarters since. The position peaked at $851K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Aaron Wealth Advisors held 944 shares of Regeneron Pharmaceuticals worth $589K as of Q2 2026.
- Aaron Wealth Advisors sold 158 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $108K.
- Regeneron Pharmaceuticals made up 0.03% of Aaron Wealth Advisors's portfolio in Q2 2026, its #375 holding.
- Aaron Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
- Aaron Wealth Advisors's Regeneron Pharmaceuticals position peaked at $851K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.